EUCTR2008-003661-19-BE进行中（未招募）1 期
Invloed van laag gedoseerde hormonale substitutie op insulinespiegels bij postmenopausale vrouwen
niversity Hospital Ghent0 个研究点开始时间: 2009年5月29日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •- Postmenopausaal
- •- Leeftijd van 65 jaar of ouder
- •- Nog geen HRT genomen in het verleden of HRT stop en 8 weken wash-out
- •- Bereid tot nemen van lage dosis oestrogenen
- •- Mammografie, maximum 1 jaar geleden
- •- BMI = 25 of BMI > 25
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Voorgeschiedenis van hormoongevoelige tumoren (bv. borstkanker, endometriumkanker,..)
- •- Contra-indicaties voor hormonale substitutie therapie (bv. CVA, trombosen, …)
- •- Diabetes
- •- Afwijkend klinisch onderzoek bij aanvang van de studie (verdikt endometrium op echo, palpabele borstnodus, ovariële cyste op echo,…).
研究者
相似试验
已完成
不适用
The Effect of Low Dose Hormone Replacement Therapy or Raloxifene on Bone and Lipid Metabolism in Hemodialysis PatientsPostmenopausal osteopenia in hemodialysis patientsJPRN-C000000390Department of Nephrology, Osaka University School of Medicine39
进行中（未招募）
不适用
Den endokrine effekt af enten r-LH eller lav dosis r-hCG tilskud til r-FSH stimulering hos normogonadotrope kvinder som gennemgår IVF/ICSI behandling efter en lang GnRH agonist nedreguleringsprotocol - Et prospektivt randomiseret kontrolleret ikke blindet pilot studieFertilitetsbehandling.Sammenligne de endokrine effekter, specielt E2 niveau på hCG dagen hos normogonadatrope IVF/ICSI patienter, som får tilskud af LH aktivitet i form af enten rhCG eller rLHMedDRA version: 9.1Level: LLTClassification code 10016398Term: Female infertilityEUCTR2009-009375-35-DKRegionshospital skive
进行中（未招募）
不适用
Modulation of response to hormonal therapy with lapatinib and/or metformin in patients with HER2-negative, ER and/or PgR positive metastatic breast cancer with progressive disease after first-line hormonal therapyFemale patients with HER2-negative, ER and/or PgR positive breast cancer in progression after first-line hormonal therapyMedDRA version: 14.1Level: SOCClassification code 10038604Term: Reproductive system and breast disordersSystem Organ Class: 10038604 - Reproductive system and breast disordersEUCTR2011-000155-16-ITFONDAZIONE MICHELANGELO - AVANZAMENTO DELLO STUDIO E CURA DEI TUMORI
已完成
3 期
Comparative effects of 2 types of hormone replacement therapy on climacteric symptomsmenopause.Menopausal and female climacteric statesIRCT138809032766N1Tarbiat Maodares University150
已完成
2 期
Effect of hormonal therapy versus no treatment on testicular histopathology and fertility in patients with non-obstructive azoospermianon-obstructive azoospermia.Male infertilityIRCT201612069014N137Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences28